Captor Capital Corp
F:NMVA
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (10.4), the stock would be worth €-14.27 (5 675% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.2 | €0.26 |
0%
|
| Industry Average | 10.4 | €-14.27 |
-5 675%
|
| Country Average | 10.9 | €-15.1 |
-5 998%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
C
|
Captor Capital Corp
F:NMVA
|
924k EUR | -0.2 | -0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD | 61.4 | 47.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD | 24.2 | 22.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
298.4B CHF | 15.5 | 31.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP | 22.3 | 31.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.3B CHF | 16.7 | 22.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD | 18.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 809.8 | -74.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 9.2 | 10.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 11.8 | 19.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD | 8.8 | 17.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 7.2 |
| Median | 10.9 |
| 70th Percentile | 17 |
| Max | 26 053.9 |
Other Multiples
Captor Capital Corp
Glance View
Captor Capital Corp. is an investment company. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-10-30. The firm cultivates, manufactures and distributes medical marijuana-based products to consumers through its brands and dispensary retail stores. The firm provides cannabis products, as well as other cannabis-based goods. The Company’s California joint venture portfolio consists two CHAI Cannabis Co. branded dispensaries, four One Plant branded dispensaries and three additional California cannabis retail licenses for stores under construction. CHAI Santa Cruz is a medical and cannabis dispensary in Santa Cruz County.
